Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 7, Pages e39949
Publisher
Public Library of Science (PLoS)
Online
2012-07-19
DOI
10.1371/journal.pone.0039949
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apoptosis-related protein-2 triggers melanoma cell death by a mechanism including both endoplasmic reticulum stress and mitochondrial dysregulation
- (2011) D. Selimovic et al. CARCINOGENESIS
- Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells
- (2010) B M Madhok et al. BRITISH JOURNAL OF CANCER
- Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs
- (2010) Dirk Heshe et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC
- (2010) Luke H. Stockwin et al. INTERNATIONAL JOURNAL OF CANCER
- Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?
- (2010) Ioanna Papandreou et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
- (2010) A. Le et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic Modulation of Glioblastoma with Dichloroacetate
- (2010) E. D. Michelakis et al. Science Translational Medicine
- Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress
- (2009) Maria Marchetti et al. PLoS One
- Sulindac confers high level ischemic protection to the heart through late preconditioning mechanisms
- (2009) I. Moench et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Role of dichloroacetate in the treatment of genetic mitochondrial diseases☆
- (2008) Peter W. Stacpoole et al. ADVANCED DRUG DELIVERY REVIEWS
- Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
- (2008) E D Michelakis et al. BRITISH JOURNAL OF CANCER
- Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
- (2008) Frank L. Meyskens et al. Cancer Prevention Research
- Brick by brick: metabolism and tumor cell growth
- (2008) Ralph J DeBerardinis et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Dichloroacetate induces apoptosis in endometrial cancer cells
- (2008) Jason Y.Y. Wong et al. GYNECOLOGIC ONCOLOGY
- A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation
- (2008) Hyeon-Ok Jin et al. LUNG CANCER
- Evaluation of Long-term Treatment of Children With Congenital Lactic Acidosis With Dichloroacetate
- (2008) P. W. Stacpoole et al. PEDIATRICS
- Dichloroacetate (DCA) sensitizes both wild‐type and over expressingBcl‐2prostate cancer cells in vitro to radiation
- (2008) Wengang Cao et al. PROSTATE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started